Cargando…
Strategies to Circumvent the Side-Effects of Immunotherapy Using Allogeneic CAR-T Cells and Boost Its Efficacy: Results of Recent Clinical Trials
Despite the outstanding results of treatment using autologous chimeric antigen receptor T cells (CAR-T cells) in hematological malignancies, this approach is endowed with several constraints. In particular, profound lymphopenia in some patients and the inability to manufacture products with predefin...
Autores principales: | Smirnov, Sergei, Petukhov, Alexey, Levchuk, Ksenia, Kulemzin, Sergey, Staliarova, Alena, Lepik, Kirill, Shuvalov, Oleg, Zaritskey, Andrey, Daks, Alexandra, Fedorova, Olga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714645/ https://www.ncbi.nlm.nih.gov/pubmed/34975869 http://dx.doi.org/10.3389/fimmu.2021.780145 |
Ejemplares similares
-
The biological basis and clinical symptoms of CAR-T therapy-associated toxicites
por: Titov, Aleksei, et al.
Publicado: (2018) -
Case Report: Primary Leptomeningeal Medulloblastoma in a Child: Clinical Case Report and Literature Review
por: Morgacheva, Daria, et al.
Publicado: (2022) -
Linking Metabolic Reprogramming, Plasticity and Tumor Progression
por: Shuvalov, Oleg, et al.
Publicado: (2021) -
Attenuation of p53 mutant as an approach for treatment Her2-positive cancer
por: Fedorova, Olga, et al.
Publicado: (2020) -
Emerging roles of cancer-testis antigenes, semenogelin 1 and 2, in neoplastic cells
por: Shuvalov, Oleg, et al.
Publicado: (2021)